| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $247.2M | -14.9% | +5.5% |
| Cost of Revenue | $110.4M | — | -4.8% |
| Gross Profit | $136.8M | -18.3% | +15.5% |
| R&D Expense | $46.0M | — | -8.3% |
| SG&A Expense | $108.2M | -32.0% | -5.0% |
| Operating Income | -$17.4M | -310.2% | +85.6% |
| Pre-tax Income | -$19.9M | — | +83.7% |
| Income Tax | $516K | — | -93.9% |
| Net Income | -$20.4M | -3362.3% | +84.4% |
| EPS (Basic) | -$0.30 | -2900.0% | +84.8% |
| EPS (Diluted) | -$0.30 | -2900.0% | +84.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $179.3M | +97.9% | +234.7% |
| Short-term Investments | $390.9M | +93.5% | +24.1% |
| Accounts Receivable | $140.7M | -15.0% | +11.1% |
| Inventory | $126.4M | -1.8% | -10.5% |
| Current Assets | $887.1M | +43.5% | +33.7% |
| Total Assets | $1.15B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $11.1M | — | +160.5% |
| Capital Expenditures | $6.3M | — | +111.4% |
| Investing Cash Flow | -$195.4M | — | -2227.7% |
| Financing Cash Flow | $274.2M | — | +5948.1% |
| Free Cash Flow | $4.8M | — | +122.5% |
| +25.1% |
| Current Liabilities | $248.0M | +2.2% | -14.0% |
| Long-term Debt | $601.8M | +94.1% | +94.9% |
| Total Liabilities | $1.02B | +40.6% | +33.1% |
| Stockholders' Equity | $132.4M | -14.7% | -14.7% |